RUBRACA: New Drug Trials Snapshot Posted

 A new DRUG TRIALS SNAPSHOT FOR RUBRACA is now available.

RUBRACA is a drug used to treat women with advanced ovarian cancer who:

• have certain BRCA gene mutation (either inherited or acquired), and
• have received previous treatment with 2 or more chemotherapy medicines for their cancer.

Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.

See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov.